This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
This is a test.
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
This is a test.
Developing new treatments for clear cell ovarian cancer
This is a test.
Developing optimal treatment combinations for small cell carcinoma of the ovary
This is a test.
Supercharging CAR-T cells for Ovarian Cancer
This is a test.
Development of therapeutic vaccines against ovarian cancer
This is a test.
Tumour testing and ovarian cancer drug prediction program
This is a test.
Targeting epitranscriptomic mechanisms in ovarian cancer
This is a test.
Exploring and exploiting aberrant RBX1 expression in high-grade serous ovarian cancer (HGSOC)
